Zhang, Fei <br/><br/>
20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway.  [electronic resource] 

 -  Drug design, development and therapy  2015 
 - 3969-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1177-8881 
<br/><br/><label>Standard No.: </label>10.2147/DDDT.S84527  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Caspases--metabolism<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cellular Senescence--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>Dose-Response Relationship, Drug<br/>Gallbladder Neoplasms--drug therapy<br/>Ginsenosides--pharmacology<br/>Humans<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mitochondria--drug effects<br/>Proto-Oncogene Proteins c-mdm2--metabolism<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Tumor Burden--drug effects<br/>Tumor Suppressor Protein p53--metabolism<br/>Xenograft Model Antitumor Assays